BioSpace News Archive

Biotech Bay

Nile Therapeutics, Inc. Announces Filing of Annual and Quarterly Reports to Become Current on SEC Filings

June 24, 2013
·
1 min read
Biotech Bay

Anthera Pharmaceuticals, Inc. Announces Receipt of Nasdaq Notice

June 24, 2013
·
2 min read
Deals

KKR Snaps Up PRA International, Inc. for $1.3 Billion

June 24, 2013
·
2 min read
Drug Development

Eli Lilly and Company Release: Phase III Study Finds Investigational Agent Empagliflozin Significantly Reduced Blood Glucose in Adults With Type 2 Diabetes and Impaired Kidney Function

June 24, 2013
·
9 min read
Drug Development

Eli Lilly and Company Release: Phase III Data Show Significant Reductions in Blood Glucose With Investigational Compound Empagliflozin Used as Monotherapy in Adults With Type 2 Diabetes

June 24, 2013
·
8 min read
Pharm Country

Aris Global, LLC Improves Sponsor-To-Site Management With Clinical Investigator Portal

June 24, 2013
·
3 min read
Drug Development

Eli Lilly and Company Relase: Phase III Data Show Significant Reduction in Blood Glucose With Investigational Compound Empagliflozin Added to Metformin or Metformin Plus Sulfonylurea in Adults With Type 2 Diabetes

June 24, 2013
·
9 min read
Pharm Country

Aris Global, LLC Wins Prestigious Frost & Sullivan Pharmacovigilance Customer Value Enhancement Award

June 24, 2013
·
3 min read
Policy

Sanofi (France) CEO: EU Open Data Plan Would Hurt Drugmakers

June 24, 2013
·
1 min read
Drug Development

Eli Lilly and Company Release: Phase III Data Show Investigational Compound Empagliflozin Plus Insulin Significantly Reduced Hba1c in Adults With Type 2 Diabetes

June 24, 2013
·
7 min read